Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sodium shale oil sulfonate NDA filed by International Sourcing for dandruff, blemishes.

This article was originally published in The Tan Sheet

Executive Summary

SODIUM SHALE OIL SULFONATE NDA FOR OTC USE of the ingredient in products for treatment of dandruff and blemishes recently has been submitted to FDA, Gudrun Mays, PhD, Ichthyol-Gesellschaft, Cordes, Hermanni & Co., said at a June 11 HBA Global Expo seminar in New York City. The Hamburg, Germany-based company is working in conjunction with Upper Saddle River, N.J.-based International Sourcing. SSOS is marketed in Germany and France in shampoos and acne products.

You may also be interested in...



German Firm Hopes To Drill Into U.S. Market With Anti-Dandruff Ingredient

Ichthyol-Gesellschaft is looking to introduce sodium shale oil sulfonate into FDA's OTC monograph so the ingredient can be generally recognized as safe and effective as a treatment for dandruff

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087188

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel